U.S. health safety watchdog under HHS
Vivani Medical and Novo Nordisk are exploring a long-acting semaglutide implant to maintain weight loss, potentially replacing frequent injections. The device aims to release medicine steadily for months, pending clinical and regulatory validation.
Recent studies have shown significant advances in gene therapy for hearing loss and eye conditions, as well as promising research on reversing brain inflammation linked to aging. Meanwhile, new evidence questions the effectiveness of Alzheimer’s drugs, highlighting ongoing challenges in neurodegenerative treatments. Today's date is Mon, 27 Apr 2026 11:37:39 +0100.
The US government has implemented new policies to accelerate research and development of psychedelics, including psilocybin, MDMA, and ibogaine. The move involves FDA fast-tracking and funding for state-level studies, aiming to improve treatments for mental health and addiction. This follows recent political and scientific developments.
USC researchers have found that young non-smokers with high-quality diets may have a higher incidence of early-onset lung cancer. The study analyzes 187 patients under 50 and links higher Healthy Eating Index scores to cancer biology that differs from smoking-related cases. Researchers point to possible pesticide exposure as a leading theory while noting ongoing questions.
The UK has passed the Tobacco and Vapes Act, which has created a rolling age ban that will permanently prevent anyone born on or after 1 January 2009 from legally buying tobacco. The law has also granted ministers broad powers to regulate vaping — including flavours, packaging, displays and where vaping is allowed — and will tighten sales rules for under‑18s.
President Trump has acknowledged that his previous claims of reducing drug prices by over 100% are mathematically impossible. During a drug pricing event, he explained his use of different calculation methods and defended his efforts to lower medication costs through new deals with pharmaceutical companies, including Regeneron.
A unanimous 5th Circuit ruling has blocked mail distribution of mifepristone, requiring in-person dispensing at clinics. The decision, which has immediate effect and is likely to be appealed to the Supreme Court, challenges FDA regulations as a breach of state bans and raises questions about access to medication abortion nationwide.
The Supreme Court is weighing an emergency petition to pause a Fifth Circuit ruling that would restrict mifepristone access, while allowing telemedicine and mail delivery to continue for now. The government and manufacturers urge a rapid decision, as lower-court moves threaten broad abortion access.
Health guidance has shifted to emphasize animal proteins and nutrient density, while hospitals have previously implemented plant-forward meals. The new federal guidelines prioritize animal sources and warn about potential gaps in plant-based diets, provoking debate among clinicians and policy-makers.
The Supreme Court has issued an emergency order keeping mifepristone available by mail and via telehealth while litigation continues. The action preserves access as lawsuits challenge FDA rules on prescribing the abortion pill, with a ruling likely not until next year.
Weight-loss GLP-1 drugs are expanding beyond injections to pills in the US, UK and UAE. Major manufacturers report rising uptake and ongoing development, with Medicare and NHS access shaping pace and affordability. Private prescriptions and new formulations are widening access while competition accelerates.
Since 2025, measles outbreaks have spread in unvaccinated communities in the United States, prompting therapeutic research and policy debates. Outbreaks have climbed nationally, with California and other states reporting rising case counts and hospitalizations. Experts warn that misinformation compounds transmission, while high vaccination coverage remains vital for herd immunity.
GSK has struck a multi-billion deal to acquire Nuvalent, adding three late-stage cancer drugs to its portfolio, including two lung-cancer therapies under FDA review. The acquisition aims to boost sales growth, expand the lung-cancer platform, and position GSK for a potential rise in annual revenue by 2031.
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, marking a modernization in U.S. UV protection. The ingredient absorbs both UVA and UVB rays, is photostable, and will debut as Parsol Shield before broader market adoption after an 18‑month exclusivity period. Industry and dermatology experts say the move could improve protection and user experience, though rollout and formulation timelines remain.
The FDA has approved bemotrizinol, a chemical UV filter used in European and Asian sunscreens for over 20 years. It offers UVA and UVB protection, is photostable, and may lead to more elegant, higher-SPF products in the US. The move comes after decades of FDA inaction on new filters, with products containing bemotrizinol expected to reach US shelves after about 18 months.
A new CMS rule redefines medical frailty for Medicaid expansions, threatening to bar exemptions for some patients who are too sick to work. The guidance requires proof that conditions “significantly impair” work ability, potentially affecting many patients who rely on treatment while facing complex paperwork and renewal hurdles.
AP News reports a large sauce recall linked to possible salmonella contamination. Independent Business highlights rising alpha-gal meat allergy due to tick bites, while New York Post Business covers a listeria outbreak tied to soft cheese and new guidance on early meat introduction to combat allergies. The articles reflect ongoing food safety concerns and evolving medical guidance.
Reports show rising youth nicotine use and regulatory debates over fruit-flavored vapes. The FDA has approved some flavors for adults; critics warn this may attract teens. Experts urge stronger prevention and clearer guidance.
[Synopsis here]
The FDA has recalled all Nara Organics Whole Milk Organic Infant Formula after three babies aged 2–5 months in California, Pennsylvania and Washington hospitalised with infant botulism. The formula, sold nationwide online and in Target stores, accounts for less than 1% of US infant formula; the FDA says there are no shortage concerns. Parents are urged to stop using the product and contact refunds. BabyBIG is the approved treatment.
A cluster of benzodiazepine-contaminated Prinok baby purees has prompted a health inquiry in Jerusalem; meanwhile, teen Benny Benadryl challenges have led to ICU cases in the U.S. and warnings from the FDA and health officials. Separate reports outline GLP-1 overdoses and ongoing Benadryl-related fatalities, urging vigilance and safer practices.
A Japanese approval for Telomelysin offers a gentler option for esophageal cancer patients ineligible for surgery. Other studies show CAR T-cell therapy remains transformative for certain cancers, while nanotechnology and immunotherapies highlight ongoing progress with meaningful patient impact.
Moderna’s mFlusiva has secured an advisory committee vote in favor of approval for adults 50 and older. The decision follows earlier FDA scrutiny and a high-profile dispute over study design, with the committee citing robust efficacy and a solid safety profile.
Pfizer has reported that its experimental drug sigvotatug vedotin did not improve survival in advanced non‑small cell lung cancer compared with standard therapy. The result setbacks expectations for a potential first‑in‑class antibody‑drug conjugate and follows Pfizer’s 2023 Seagen purchase.
Miller has had misdemeanor drug charges dismissed in Fremont County after authorities cited new information; he has pleaded not guilty to possession of psilocybin mushrooms and his attorney says he did not have drugs on him at the time of arrest. A related active case is cited, with no details released.
A New York judge has issued a temporary restraining order to block access to confidential medical records tied to transgender care, citing patient privacy. The order follows government requests and subpoenas related to an FDA-related probe, with a follow-up hearing set for July 8 to decide on a broader injunction.
The Supreme Court has ruled 7-2 that federal pesticide law bars state failure-to-warn lawsuits over Roundup, overturning a $1.25m jury verdict and imperilling thousands of similar claims against Bayer. The decision follows the EPAs position that glyphosate is unlikely to cause cancer and clears the way for dismissal of many pending suits.
The Humboldt County Sheriff’s Office has expanded its animal cruelty and fraud investigation into Miranda’s Rescue in Fortuna, California. Since January 2025, about 900 dogs were transferred to the sanctuary, but only 116 have been adopted, leaving over 700 unaccounted for. Ground-penetrating radar and excavations have uncovered dozens of dog remains, a horse, and hundreds of bones. Authorities describe the scene as a mass grave and are examining potential fraud and mismanagement.
California has moved to standardize consumer-facing food date labels, banning “sell by” dates and introducing two main labels: “Best if Used By” for quality and “Use By” for safety. The change aims to reduce food waste and climate-warming emissions, with New York pursuing a similar path. Implementation begins July 1, 2026, with some older stock remaining in stores during the transition.
The FDA has classified Utz’s recall of Zapp’s and Dirty chips as Class 1, indicating a serious health risk. The recall covers several product lines with best-by dates July 27–August 31, 2026. Utz first issued the recall in April after a third-party dry milk powder seasoning ingredient was flagged as a possible Salmonella source; thus far, no illnesses have been reported. Consumers should discard affected chips or seek refunds.
British American Tobacco is cutting about 5,500 jobs and outsourcing 3,500 more as it shifts toward vaping, nicotine pouches and digital operations. The company says the savings target is about 600 million pounds annually by 2028, with the US not affected. The cuts come as it faces slower cigarette sales and rising regulatory and tax pressures in various markets.
A new weight‑loss pill version of semaglutide has launched in the UK for private prescriptions, offering an alternative to injections. The tablet requires strict dosing and a fasting routine and is not yet NHS‑funded. Several outlets warn about counterfeit pills as access broadens.
The NHS is expanding an AI-driven triage tool across app users, directing patients to the right service and reducing wait times. Trials show a 29% drop in GP phone queue lines, and the program is part of a larger £10bn tech overhaul. Safety, privacy, and digital inclusion remain priorities as the rollout reaches 200,000 patients this year and all users by 2028.
The 340B program, which lets hospitals buy discounted outpatient drugs for low-income patients, is facing a new CMS rule changing reimbursement formulas to reduce payments by about 40%. The move aims to lower patient costs but could shrink hospital revenues and affect services and jobs. The rule follows an executive order in 2025 and reflects ongoing political battles between hospitals and the pharmaceutical industry.
A federal class-action suit in Washington state accuses Costco of selling Orgain Organic Protein Powder with undisclosed levels of lead, cadmium and arsenic. Plaintiffs say testing by third parties and Consumer Reports shows contamination, while Orgain asserts products are safe and compliant. The case builds on similar claims and ongoing scrutiny of protein powders.
Health Secretary has announced plans to treat e-cigarettes like tobacco, moving them behind counters and removing displays in shops, airports and duty-free zones. The move aims to curb youth vaping while acknowledging vapes’ role in helping adults quit smoking.
A U.S. appeals court has revived private lawsuits alleging a link between prenatal acetaminophen exposure and autism/ADHD, reversing a district court that had excluded expert testimony. The panel says the doctors’ methodologies reflect scientific disagreement and are admissible, returning the case to ongoing proceedings.
A widespread outbreak of cyclosporiasis linked to leafy greens is expanding across the United States. Michigan reports thousands of cases as authorities investigate a potential link to Taco Bell and other produce sources. Health officials warn the outbreak is likely to continue through August; precautions include thoroughly washing produce or cooking it.
Cyclosporiasis infections have surged across the U.S., with Michigan as the hardest hit. Officials say lettuce or salad greens may be a potential source, though no specific item or supplier has been confirmed. CDC data show thousands of cases and hospitalizations, while investigations continue into possible links to produce items and outlets.
The Pentagon has rolled out annual testosterone screenings for service members aged 30 and older, with younger troops able to volunteer. Officials describe the measure as part of maintaining a “strong, resilient and capable” fighting force, while experts warn on possible health risks and ethical concerns about medical oversight.
The FDA has approved Lipfendra, Merck’s oral PCSK9 inhibitor, to lower LDL cholesterol in patients on statins. Trials show ~55-60% LDL reductions; the pill will be sold at about $315/month and must be taken on an empty stomach. Analysts see potential peak sales in the billions as injectable rivals face competition and access barriers.
Federal health officials have confirmed that shredded iceberg lettuce from a single Mexican supplier served to Taco Bell in five U.S. states is the source of a cyclospora outbreak. Taco Bell has stopped using that supplier, while authorities warn consumers to avoid the affected lettuce and to monitor further guidance.